CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- 4 Open-market sale Executive VP, Drug Development sold 494 shares at $30.62 ($15,125)
- 4 Open-market sale Executive VP, Drug Development sold 6,000 shares at $32.07 ($192,433)
- 4 Exercise or conversion Chief Executive Officer acquired 19,675 shares (option exercise)
- 4 Open-market sale Director sold 2,695,000 shares at $35.75 ($96,346,250)
- 4 Open-market sale Executive VP, Drug Development sold 6,000 shares at an average $37.53 ($225,179)
- 4 Open-market sale CFO & SVP, Finance sold 30,000 shares at an average $38.17 ($1,145,230)
- 4 Open-market sale President sold 225,000 shares at an average $38.98 ($8,769,818)
- 4 Open-market sale Chief Executive Officer sold 50,000 shares at $39.05 ($1,952,500)
- 4 Open-market buy Director bought 192,308 shares at $26.00 ($5,000,008)
- 4 Open-market sale Executive VP, Drug Development sold 18,000 shares at $30.00 ($540,000)
- 4 Open-market sale Chief Executive Officer sold 100,000 shares at $29.75 ($2,975,000)
- 4 Open-market sale Chief Executive Officer sold 100,000 shares at $24.75 ($2,475,000)
- 4 Open-market sale Executive VP, Drug Development sold 7,584 shares at $20.00 ($151,680)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Chief Executive Officer acquired 1,684 shares (other)
- 4 Derivatives Options or other derivatives
Page 14 of 30 · 585 filings